SlideShare una empresa de Scribd logo
1 de 28
Chemical Development
Capabilities Presentation
Centrally Located on America’s North Coast

43-acre site near Cleveland, Ohio

                                    Three main buildings:

                                       • 260,000 square feet
                                       • 125 well-equipped labs
                                       • 4 cGMP kilo labs
                                       • 6 general-purpose kilo labs
                                       • Plant production facility
                                       • 8 isolation/finishing suites
                                       • 43 animal rooms
                                            - 7 BSL2 Rated
                                       • Cell culture suite
                                       • Advanced LC/MS/MS lab
Focused on Our Clients’ Needs

• Established in 1986
• Annual growth rate of 20% for last four years
• Completed projects for >450 clients ─ virtual
  biotech to global pharma
• Contributed to 8% of all US INDs filed by
  biotechnology companies in 2007
• >100 APIs produced – KL and plant scale
• >200 quality audits passed
• Excellent process safety and environmental
  compliance record
Our People – Experienced, Motivated, Collaborative


  • Total company staff of 300
  • >35% with Ricerca for >10 years
  • Chemical Development (CD) staff
    of 93
  • Average industrial experience in CD
    is >13 years
  • >50% of technical staff hold
    advanced degrees
Primary Services

Drug Development Biology     Medicinal Chemistry
• Animal Models of Disease   Chemical Development
• Drug Safety Assessment     • Process Research &
   - Toxicology                Development
   - Safety Pharmacology     • Scale-up & Demonstration

• Pharmacokinetics           • Analytical Methods

• Drug Metabolism              Development & Compound
                               Characterization
   - In vitro and In vivo
                             • API Preparation
• Bioanalytical Methods
                             • Technology Transfer
  Development & Sample
  Processing                 • Regulatory Support

• Regulatory Support         • Project Management

• Project Management
Chemical Development – Our People

              Motivated professionals working in
        interdisciplinary teams to execute your project
               Analytical        Process    Process Development
               Chemistry        Chemistry     and Engineering
   PhD             7                15               1
   MS             21                7                3
   BS              5                4                4
Technician                          5
 Operator                                           21
  Total           33               31               29

  Years of
 Industrial      > 13             > 13             > 22
Experience
Chemical Development – Our Strengths

• Organic Chemistry – expert in established reactions
  with the ability to rapidly master new innovative
  technologies
• Analytical Chemistry – diversified analytical
  expertise applied to solve problems and support
  development programs
• Process Development & Scale-up – rapid conversion
  of a discovery route into a commercially-viable
  process with demonstration in the pilot plant
• Custom Processing – rapid production of products
  to support the development program
Chemical Development – Our Services

Process Chemistry
• Chemical route evaluation & selection
• Process research
• Process justification and robustness testing
Process Development & Engineering
• Process development
• Scale-up & demonstration
• Process optimization and cost analysis
• Process validation
• Technology transfer
Chemical Development – Our Services

Analytical Chemistry
• Methods development and validation – phase
  appropriate
• Reference standard characterization
• Impurity & metabolite ID and characterization
• Forced degradation studies
• Photostability studies
• Storage stability studies
• Salt screening and selection
• Polymorph identification & characterization
• API release testing for research & commercial use
Chemical Development – Our Services

API Preparations & Manufacturing
• API preparation for preclinical use
• API preparation for clinical use using cGMP
  controls
• Commercial API manufacturing – selective basis
• Preparation of reference standards, impurities, &
  metabolites
• Radiolabeled synthesis – using cGMP controls
  when needed
Regulatory Support
• CMC section preparation for IND filing
• Regulatory consultation
Putting It All Together – Project Management

•   Multi-disciplinary team led by Project
    Leader
•   Project Leader is key client interface –
    your “Go To” person
•   Direct and frequent communication –
    “the good, the bad, and the ugly”
•   Direct access to team members
•   Rapid and flexible response to project
    scope changes
Drug Development Program - Phase I
              Technology Input – Discovery Route
Preclinical to Phase I
   •   Chemical route assessment
   •   Chemical route modification
   •   API method development – purity (stability-indicating),
       impurities, residual solvents, counter-ion, process residues
   •   API preparation and characterization for use in toxicology
       studies
   •   Phase I process research – safety, reliability, scale-ability
   •   API preparation and characterization for Phase I clinical trials
   •   API physical and chemical characterization
   •   CMC documentation package preparation


              IND Granted – Phase I Trials Successful!
Drug Development Program - Phase II

Phase II - API Chemical Development and Supply
•   Applied process research and development
     - Supported by economic modeling
     - Establish commercially-viable API production process
•   API process scale-up and demonstration
•   API methods refinement
•   API preparation and characterization for Phase II clinical
    trials
•   API production technology documentation
•   Program is customized to meet specific client requirements


                      Phase II Trials Successful!
Drug Development Program – Phase III

Phase III – Validation and API Supply
•   Process Justification – critical process parameters and critical
    quality attributes
•   Analytical Methods Validation for commercial use
•   Process Validation
•   NDA Lot Production – 3 Lots
•   NDA Lot Storage Stability Program – 3 Lots
•   Process Documentation for NDA submission


           Commercial Launch and Production
Our Quality System

•   Full compliance with the ICH Q7A Harmonized
    Guidelines for current Good Manufacturing
    Practices (GMPs) for Active Pharmaceutical
    Ingredients (APIs)
•   Excellent compliance record – passed audits by
    >200 clients and US FDA
•   Passed first US FDA PAI in late 2007
•   System incorporates best practices developed
    by interaction with our diverse client base
•   Our challenge – balance compliance, cost, and
    timing
Our Tools – Process Chemistry

Process Research Laboratories
   •   General purpose – mg to kg
   •   Processing scale - up to 12 liters
   •   Pressure range: FV to 50 psig
   •   Temp range: -78 to +200 ºC

Radiochemistry Labs - 4
   •   Licensed for 3H, 14C, 32P, 35S, 131I, 125I,
       99Tc, 36Cl


cGMP Kilo Labs - 4
   •   HEPA-filtered air system
   •   Processing scale to 50 liters
   •   Temperature range: -78 to +200 ºC
   •   Dedicated single project use

General Purpose Kilo Labs - 6
Our Tools – Process Chemistry




   Radiochemistry




                            cGMP Kilo Lab
Our Tools – Analytical Chemistry

FDA-, cGMP-, GLP-, ICH-, EPA-, and OPECD- Compliant

•   Atomic spectroscopy   AA, ETAAS, ICP
•   Chromatography        GC, LC, IC, GPC
•   Microscopy            Optical, Polarized, Hot-stage, Raman
•   Microbiology          LAL, Bioburden
•   Molecular             FTIR, FT-NMR, GC/MS, Raman
                          LC-MS/MS, LC-MS, UV
•   Thermal analysis      DSC, TGA, HSM, XRD
•   X-ray analysis        Combinatorial, Temp, Humidity
•   Physical testing      Particle size, Density, pka, logP, logD
•   Water analysis        KF, DVS, Static vapor
•   Solubility            Tecan, Safire, Nephelometric
Our Tools – Analytical Chemistry




Automated XRD

                                     HPLC Systems




                      NMR Center
Our Tools – Plant Facility
        Three-story cGMP facility
        • Batch and continuous processing
        • Isolation/finishing rooms
        • Process and IPC testing labs
Our Tools – Plant Reaction Systems
                    Multipurpose Pilot Plants

Reaction Systems
• 17 reactors
• Total capacity = 17,000 liters
• Sizes from 40 to 3,000 liters
• MOC – GLS and 316SS
• FV to 400 psig
• - 55 to +165°C
Our Tools – Processing Support Equipment

Support Equipment
• Separations (Liquid/Liquid)
  - Batch distillation – custom
    design
  - Thin-film/wiped film evaporator
• Separations (Solid/Liquid)
  - Centrifuges
  - Pressure/vacuum filters
• Flash Chromatography
  - 40-kg SG cartridge
• Drying
  - Rotary cone
  - Vacuum shelf
Our Tools – Plant Facility

                                 400-Liter GLS Reaction System




Shelf Dryer in Finishing Suite
A Proven Track Record


First Pharma ceutical P roject               19 87
Pharma ceutical P rojects                    > 220
APIs P roduced                               > 100
API Int ermedia tes Produce d                 > 30
APIs a nd Interme diate s Produced       > 5 ,50 0 kgs
Technology Transfers                           18

             Most Complex API Project
                  16 chemical steps
           1 chiral center – 100 kilograms
The Benefits We Bring

•   Chemistry – Engineering synergy results in
    development of robust practical process
•   Experienced, motivated, and collaborative staff
    that excels at executing challenging projects
•   Continuity of API supply – preclinical to
    commercial production – all at one site
•   Collaborative partnership approach
•   Proven capability to develop and transfer
    technology to CMO (if needed)
•   Commitment to quality and continuous
    improvement
Project Profile - Background

•   Young biotech company
•   New indication for licensed-in compound
•   Small molecule
•   Limited process and analytical information
•   Chemical route selected
•   Process consisted of 4 reaction/isolation
    segments
•   Project requirements:
     - Supply API for clinical program
     - Develop manufacturing process
Project Profile - Outcome

•   Original process benchmarked and used to
    prepare initial API supply
•   Process changes identified, tested, and reduced
    to practice
•   Significant process changes were:
     - two processing segments combined into one
     - cycle time for limiting step reduced by 5X
     - productivity of limiting step increased by 4X


     Net effect - throughput increased by 3X
Project Profile – Outcome

•   Improved process successfully demonstrated at
    400- liter scale
•   Manufacturing cost reduced by 50%
•   API supplied for clinical program through Phase IIB
•   Complete analytical methods package developed
•   Technology transferred to commercial partner
•   Technology successfully demonstrated at 8,000-liter
    scale
•   Product launched worldwide in 2003

Más contenido relacionado

La actualidad más candente

Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...MilliporeSigma
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturingbio-link
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...KBI Biopharma
 
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...KBI Biopharma
 
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy
 
Formulation Development Services
Formulation Development ServicesFormulation Development Services
Formulation Development ServicesKemwell Biopharma
 
Orphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOOrphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOKBI Biopharma
 
PD230 Catalytic Reforming
PD230 Catalytic ReformingPD230 Catalytic Reforming
PD230 Catalytic ReformingpetroEDGE
 
Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...
Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...
Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...MilliporeSigma
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsKBI Biopharma
 
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...MilliporeSigma
 
High-throughput Miniaturized Bioreactors for Cell Culture Process Developmen...
High-throughput Miniaturized Bioreactors for Cell Culture  Process Developmen...High-throughput Miniaturized Bioreactors for Cell Culture  Process Developmen...
High-throughput Miniaturized Bioreactors for Cell Culture Process Developmen...KBI Biopharma
 

La actualidad más candente (20)

Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturing
 
lesliehenson-grochocki
lesliehenson-grochockilesliehenson-grochocki
lesliehenson-grochocki
 
PharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing ServicesPharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing Services
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
 
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
 
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
 
Cell line development services
Cell line development servicesCell line development services
Cell line development services
 
Formulation Development Services
Formulation Development ServicesFormulation Development Services
Formulation Development Services
 
Blue Ocean Introduction Brochure
Blue Ocean Introduction BrochureBlue Ocean Introduction Brochure
Blue Ocean Introduction Brochure
 
Orphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOOrphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMO
 
Ranjeet Resume (1)
Ranjeet Resume (1)Ranjeet Resume (1)
Ranjeet Resume (1)
 
PD230 Catalytic Reforming
PD230 Catalytic ReformingPD230 Catalytic Reforming
PD230 Catalytic Reforming
 
ActiveCV 2017
ActiveCV 2017ActiveCV 2017
ActiveCV 2017
 
Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...
Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...
Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and ...
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
 
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
 
Pressure Relief Systems
Pressure Relief Systems Pressure Relief Systems
Pressure Relief Systems
 
MD-Manager Nichols_Becky 2016
MD-Manager Nichols_Becky 2016MD-Manager Nichols_Becky 2016
MD-Manager Nichols_Becky 2016
 
High-throughput Miniaturized Bioreactors for Cell Culture Process Developmen...
High-throughput Miniaturized Bioreactors for Cell Culture  Process Developmen...High-throughput Miniaturized Bioreactors for Cell Culture  Process Developmen...
High-throughput Miniaturized Bioreactors for Cell Culture Process Developmen...
 

Destacado

Joseph P. Raia Consulting Presentation 2 26 09 Pp 97 Format
Joseph P. Raia Consulting Presentation  2 26 09   Pp 97 FormatJoseph P. Raia Consulting Presentation  2 26 09   Pp 97 Format
Joseph P. Raia Consulting Presentation 2 26 09 Pp 97 Formatjraia
 
Distimo G Star Presentation
Distimo G Star PresentationDistimo G Star Presentation
Distimo G Star PresentationRichard Pidgeon
 
4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...dominev
 
PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...
PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...
PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...Runa La-Ela
 
Chemical Spaces: Modeling, Exploration & Understanding
Chemical Spaces: Modeling, Exploration & UnderstandingChemical Spaces: Modeling, Exploration & Understanding
Chemical Spaces: Modeling, Exploration & UnderstandingRajarshi Guha
 
Narke Pda Orlando Mar2010 Boot Camp Final
Narke Pda Orlando Mar2010 Boot Camp FinalNarke Pda Orlando Mar2010 Boot Camp Final
Narke Pda Orlando Mar2010 Boot Camp Finalenarke
 
Drug Discovery & Development Overview
Drug Discovery & Development OverviewDrug Discovery & Development Overview
Drug Discovery & Development OverviewMikeSumner
 

Destacado (9)

Chemical Development
Chemical DevelopmentChemical Development
Chemical Development
 
Joseph P. Raia Consulting Presentation 2 26 09 Pp 97 Format
Joseph P. Raia Consulting Presentation  2 26 09   Pp 97 FormatJoseph P. Raia Consulting Presentation  2 26 09   Pp 97 Format
Joseph P. Raia Consulting Presentation 2 26 09 Pp 97 Format
 
Distimo G Star Presentation
Distimo G Star PresentationDistimo G Star Presentation
Distimo G Star Presentation
 
4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...
 
CASSS CMC 09Dec14 Stephan Krause
CASSS CMC 09Dec14 Stephan KrauseCASSS CMC 09Dec14 Stephan Krause
CASSS CMC 09Dec14 Stephan Krause
 
PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...
PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...
PHYSICO-CHEMICAL CHARACTERIZATION AND PRODUCT DEVELOPMENT FROM BANANA GERMPLA...
 
Chemical Spaces: Modeling, Exploration & Understanding
Chemical Spaces: Modeling, Exploration & UnderstandingChemical Spaces: Modeling, Exploration & Understanding
Chemical Spaces: Modeling, Exploration & Understanding
 
Narke Pda Orlando Mar2010 Boot Camp Final
Narke Pda Orlando Mar2010 Boot Camp FinalNarke Pda Orlando Mar2010 Boot Camp Final
Narke Pda Orlando Mar2010 Boot Camp Final
 
Drug Discovery & Development Overview
Drug Discovery & Development OverviewDrug Discovery & Development Overview
Drug Discovery & Development Overview
 

Similar a Chemical Development \'09

Chem Pacific Presentation Chemical
Chem Pacific  Presentation   ChemicalChem Pacific  Presentation   Chemical
Chem Pacific Presentation Chemicalcmcrandal
 
DCN Diagnostics. Design and Development of Lateral Flow Assay Systems
DCN Diagnostics. Design and Development of Lateral Flow Assay SystemsDCN Diagnostics. Design and Development of Lateral Flow Assay Systems
DCN Diagnostics. Design and Development of Lateral Flow Assay SystemsBrendan O'Farrell
 
AMRI Global Pharmaceutical CRAMS 2014
AMRI Global Pharmaceutical CRAMS 2014AMRI Global Pharmaceutical CRAMS 2014
AMRI Global Pharmaceutical CRAMS 2014Prashant Salve @ AMRI
 
Core rx presentation_2012
Core rx presentation_2012Core rx presentation_2012
Core rx presentation_2012jfd22222
 
Dcn inovatec presentation final
Dcn inovatec presentation finalDcn inovatec presentation final
Dcn inovatec presentation finalFabiana Tarabal
 
Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01Fabiana Tarabal
 
Pharma API Manufacturers in India
Pharma API Manufacturers in IndiaPharma API Manufacturers in India
Pharma API Manufacturers in IndiaAarti Pharmalabs
 
Susan Tao Resume 030816 linkdIn
Susan Tao Resume 030816 linkdInSusan Tao Resume 030816 linkdIn
Susan Tao Resume 030816 linkdInSusan Tao
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyMilliporeSigma
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyMerck Life Sciences
 
Cadila Pharmaceuticals R&D Presentation
Cadila Pharmaceuticals R&D PresentationCadila Pharmaceuticals R&D Presentation
Cadila Pharmaceuticals R&D PresentationRishab Agrawal
 
Quality control managment
Quality control managmentQuality control managment
Quality control managmentDr Qureshi
 
Karen cash resume_qc08262017
Karen cash resume_qc08262017Karen cash resume_qc08262017
Karen cash resume_qc08262017Karen J. Cash
 

Similar a Chemical Development \'09 (20)

Chem Pacific Presentation Chemical
Chem Pacific  Presentation   ChemicalChem Pacific  Presentation   Chemical
Chem Pacific Presentation Chemical
 
DCN Diagnostics. Design and Development of Lateral Flow Assay Systems
DCN Diagnostics. Design and Development of Lateral Flow Assay SystemsDCN Diagnostics. Design and Development of Lateral Flow Assay Systems
DCN Diagnostics. Design and Development of Lateral Flow Assay Systems
 
AMRI Global Pharmaceutical CRAMS 2014
AMRI Global Pharmaceutical CRAMS 2014AMRI Global Pharmaceutical CRAMS 2014
AMRI Global Pharmaceutical CRAMS 2014
 
Core rx presentation_2012
Core rx presentation_2012Core rx presentation_2012
Core rx presentation_2012
 
DCN Company Profile 2015
DCN Company Profile 2015DCN Company Profile 2015
DCN Company Profile 2015
 
Nextar
NextarNextar
Nextar
 
Dcn inovatec presentation final
Dcn inovatec presentation finalDcn inovatec presentation final
Dcn inovatec presentation final
 
Albemarle Continuous Reactions Presentation
Albemarle Continuous Reactions PresentationAlbemarle Continuous Reactions Presentation
Albemarle Continuous Reactions Presentation
 
Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01
 
Pharma API Manufacturers in India
Pharma API Manufacturers in IndiaPharma API Manufacturers in India
Pharma API Manufacturers in India
 
Stabicon-Corporate presentation
Stabicon-Corporate presentationStabicon-Corporate presentation
Stabicon-Corporate presentation
 
Sreeni Labs Profile
Sreeni Labs ProfileSreeni Labs Profile
Sreeni Labs Profile
 
BioDuro
BioDuro BioDuro
BioDuro
 
Resume
ResumeResume
Resume
 
Susan Tao Resume 030816 linkdIn
Susan Tao Resume 030816 linkdInSusan Tao Resume 030816 linkdIn
Susan Tao Resume 030816 linkdIn
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Cadila Pharmaceuticals R&D Presentation
Cadila Pharmaceuticals R&D PresentationCadila Pharmaceuticals R&D Presentation
Cadila Pharmaceuticals R&D Presentation
 
Quality control managment
Quality control managmentQuality control managment
Quality control managment
 
Karen cash resume_qc08262017
Karen cash resume_qc08262017Karen cash resume_qc08262017
Karen cash resume_qc08262017
 

Chemical Development \'09

  • 2. Centrally Located on America’s North Coast 43-acre site near Cleveland, Ohio Three main buildings: • 260,000 square feet • 125 well-equipped labs • 4 cGMP kilo labs • 6 general-purpose kilo labs • Plant production facility • 8 isolation/finishing suites • 43 animal rooms - 7 BSL2 Rated • Cell culture suite • Advanced LC/MS/MS lab
  • 3. Focused on Our Clients’ Needs • Established in 1986 • Annual growth rate of 20% for last four years • Completed projects for >450 clients ─ virtual biotech to global pharma • Contributed to 8% of all US INDs filed by biotechnology companies in 2007 • >100 APIs produced – KL and plant scale • >200 quality audits passed • Excellent process safety and environmental compliance record
  • 4. Our People – Experienced, Motivated, Collaborative • Total company staff of 300 • >35% with Ricerca for >10 years • Chemical Development (CD) staff of 93 • Average industrial experience in CD is >13 years • >50% of technical staff hold advanced degrees
  • 5. Primary Services Drug Development Biology Medicinal Chemistry • Animal Models of Disease Chemical Development • Drug Safety Assessment • Process Research & - Toxicology Development - Safety Pharmacology • Scale-up & Demonstration • Pharmacokinetics • Analytical Methods • Drug Metabolism Development & Compound Characterization - In vitro and In vivo • API Preparation • Bioanalytical Methods • Technology Transfer Development & Sample Processing • Regulatory Support • Regulatory Support • Project Management • Project Management
  • 6. Chemical Development – Our People Motivated professionals working in interdisciplinary teams to execute your project Analytical Process Process Development Chemistry Chemistry and Engineering PhD 7 15 1 MS 21 7 3 BS 5 4 4 Technician 5 Operator 21 Total 33 31 29 Years of Industrial > 13 > 13 > 22 Experience
  • 7. Chemical Development – Our Strengths • Organic Chemistry – expert in established reactions with the ability to rapidly master new innovative technologies • Analytical Chemistry – diversified analytical expertise applied to solve problems and support development programs • Process Development & Scale-up – rapid conversion of a discovery route into a commercially-viable process with demonstration in the pilot plant • Custom Processing – rapid production of products to support the development program
  • 8. Chemical Development – Our Services Process Chemistry • Chemical route evaluation & selection • Process research • Process justification and robustness testing Process Development & Engineering • Process development • Scale-up & demonstration • Process optimization and cost analysis • Process validation • Technology transfer
  • 9. Chemical Development – Our Services Analytical Chemistry • Methods development and validation – phase appropriate • Reference standard characterization • Impurity & metabolite ID and characterization • Forced degradation studies • Photostability studies • Storage stability studies • Salt screening and selection • Polymorph identification & characterization • API release testing for research & commercial use
  • 10. Chemical Development – Our Services API Preparations & Manufacturing • API preparation for preclinical use • API preparation for clinical use using cGMP controls • Commercial API manufacturing – selective basis • Preparation of reference standards, impurities, & metabolites • Radiolabeled synthesis – using cGMP controls when needed Regulatory Support • CMC section preparation for IND filing • Regulatory consultation
  • 11. Putting It All Together – Project Management • Multi-disciplinary team led by Project Leader • Project Leader is key client interface – your “Go To” person • Direct and frequent communication – “the good, the bad, and the ugly” • Direct access to team members • Rapid and flexible response to project scope changes
  • 12. Drug Development Program - Phase I Technology Input – Discovery Route Preclinical to Phase I • Chemical route assessment • Chemical route modification • API method development – purity (stability-indicating), impurities, residual solvents, counter-ion, process residues • API preparation and characterization for use in toxicology studies • Phase I process research – safety, reliability, scale-ability • API preparation and characterization for Phase I clinical trials • API physical and chemical characterization • CMC documentation package preparation IND Granted – Phase I Trials Successful!
  • 13. Drug Development Program - Phase II Phase II - API Chemical Development and Supply • Applied process research and development - Supported by economic modeling - Establish commercially-viable API production process • API process scale-up and demonstration • API methods refinement • API preparation and characterization for Phase II clinical trials • API production technology documentation • Program is customized to meet specific client requirements Phase II Trials Successful!
  • 14. Drug Development Program – Phase III Phase III – Validation and API Supply • Process Justification – critical process parameters and critical quality attributes • Analytical Methods Validation for commercial use • Process Validation • NDA Lot Production – 3 Lots • NDA Lot Storage Stability Program – 3 Lots • Process Documentation for NDA submission Commercial Launch and Production
  • 15. Our Quality System • Full compliance with the ICH Q7A Harmonized Guidelines for current Good Manufacturing Practices (GMPs) for Active Pharmaceutical Ingredients (APIs) • Excellent compliance record – passed audits by >200 clients and US FDA • Passed first US FDA PAI in late 2007 • System incorporates best practices developed by interaction with our diverse client base • Our challenge – balance compliance, cost, and timing
  • 16. Our Tools – Process Chemistry Process Research Laboratories • General purpose – mg to kg • Processing scale - up to 12 liters • Pressure range: FV to 50 psig • Temp range: -78 to +200 ºC Radiochemistry Labs - 4 • Licensed for 3H, 14C, 32P, 35S, 131I, 125I, 99Tc, 36Cl cGMP Kilo Labs - 4 • HEPA-filtered air system • Processing scale to 50 liters • Temperature range: -78 to +200 ºC • Dedicated single project use General Purpose Kilo Labs - 6
  • 17. Our Tools – Process Chemistry Radiochemistry cGMP Kilo Lab
  • 18. Our Tools – Analytical Chemistry FDA-, cGMP-, GLP-, ICH-, EPA-, and OPECD- Compliant • Atomic spectroscopy AA, ETAAS, ICP • Chromatography GC, LC, IC, GPC • Microscopy Optical, Polarized, Hot-stage, Raman • Microbiology LAL, Bioburden • Molecular FTIR, FT-NMR, GC/MS, Raman LC-MS/MS, LC-MS, UV • Thermal analysis DSC, TGA, HSM, XRD • X-ray analysis Combinatorial, Temp, Humidity • Physical testing Particle size, Density, pka, logP, logD • Water analysis KF, DVS, Static vapor • Solubility Tecan, Safire, Nephelometric
  • 19. Our Tools – Analytical Chemistry Automated XRD HPLC Systems NMR Center
  • 20. Our Tools – Plant Facility Three-story cGMP facility • Batch and continuous processing • Isolation/finishing rooms • Process and IPC testing labs
  • 21. Our Tools – Plant Reaction Systems Multipurpose Pilot Plants Reaction Systems • 17 reactors • Total capacity = 17,000 liters • Sizes from 40 to 3,000 liters • MOC – GLS and 316SS • FV to 400 psig • - 55 to +165°C
  • 22. Our Tools – Processing Support Equipment Support Equipment • Separations (Liquid/Liquid) - Batch distillation – custom design - Thin-film/wiped film evaporator • Separations (Solid/Liquid) - Centrifuges - Pressure/vacuum filters • Flash Chromatography - 40-kg SG cartridge • Drying - Rotary cone - Vacuum shelf
  • 23. Our Tools – Plant Facility 400-Liter GLS Reaction System Shelf Dryer in Finishing Suite
  • 24. A Proven Track Record First Pharma ceutical P roject 19 87 Pharma ceutical P rojects > 220 APIs P roduced > 100 API Int ermedia tes Produce d > 30 APIs a nd Interme diate s Produced > 5 ,50 0 kgs Technology Transfers 18 Most Complex API Project 16 chemical steps 1 chiral center – 100 kilograms
  • 25. The Benefits We Bring • Chemistry – Engineering synergy results in development of robust practical process • Experienced, motivated, and collaborative staff that excels at executing challenging projects • Continuity of API supply – preclinical to commercial production – all at one site • Collaborative partnership approach • Proven capability to develop and transfer technology to CMO (if needed) • Commitment to quality and continuous improvement
  • 26. Project Profile - Background • Young biotech company • New indication for licensed-in compound • Small molecule • Limited process and analytical information • Chemical route selected • Process consisted of 4 reaction/isolation segments • Project requirements: - Supply API for clinical program - Develop manufacturing process
  • 27. Project Profile - Outcome • Original process benchmarked and used to prepare initial API supply • Process changes identified, tested, and reduced to practice • Significant process changes were: - two processing segments combined into one - cycle time for limiting step reduced by 5X - productivity of limiting step increased by 4X Net effect - throughput increased by 3X
  • 28. Project Profile – Outcome • Improved process successfully demonstrated at 400- liter scale • Manufacturing cost reduced by 50% • API supplied for clinical program through Phase IIB • Complete analytical methods package developed • Technology transferred to commercial partner • Technology successfully demonstrated at 8,000-liter scale • Product launched worldwide in 2003